Gotham Asset Management LLC lifted its position in Mylan (NASDAQ:MYL) by 390.1% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 311,184 shares of the company’s stock after buying an additional 247,687 shares during the quarter. Gotham Asset Management LLC owned about 0.06% of Mylan worth $13,166,000 as of its most recent SEC filing.
Other large investors have also recently added to or reduced their stakes in the company. Rational Advisors LLC bought a new position in Mylan during the fourth quarter worth $190,000. First Personal Financial Services boosted its position in Mylan by 77.1% during the fourth quarter. First Personal Financial Services now owns 4,839 shares of the company’s stock worth $205,000 after purchasing an additional 2,106 shares during the period. Lombard Odier Asset Management Europe Ltd bought a new position in Mylan during the fourth quarter worth $209,000. Mycio Wealth Partners LLC bought a new position in Mylan during the fourth quarter worth $212,000. Finally, Advisor Partners LLC bought a new position in Mylan during the fourth quarter worth $214,000. 84.51% of the stock is owned by institutional investors and hedge funds.
Mylan stock opened at $41.16 on Thursday. The company has a market capitalization of $20,802.33, a PE ratio of 31.91, a P/E/G ratio of 1.28 and a beta of 1.35. Mylan has a 52 week low of $29.39 and a 52 week high of $47.82. The company has a debt-to-equity ratio of 1.06, a current ratio of 1.13 and a quick ratio of 0.73.
Mylan (NASDAQ:MYL) last posted its quarterly earnings results on Wednesday, February 28th. The company reported $1.43 EPS for the quarter, beating the Zacks’ consensus estimate of $1.41 by $0.02. The business had revenue of $3.24 billion during the quarter, compared to the consensus estimate of $3.29 billion. Mylan had a return on equity of 19.14% and a net margin of 5.84%. Mylan’s revenue for the quarter was down .9% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $1.57 earnings per share. equities analysts expect that Mylan will post 5.38 EPS for the current year.
A number of research firms have commented on MYL. Goldman Sachs lifted their price objective on shares of Mylan from $46.00 to $52.00 and gave the stock a “buy” rating in a research report on Thursday, January 11th. Citigroup reaffirmed a “buy” rating and set a $58.00 price objective (up from $48.00) on shares of Mylan in a research report on Thursday, January 4th. Leerink Swann assumed coverage on Mylan in a report on Tuesday, January 2nd. They set a “market perform” rating and a $44.00 target price for the company. TheStreet raised Mylan from a “c” rating to a “b-” rating in a report on Wednesday, January 17th. Finally, JPMorgan Chase & Co. set a $53.00 target price on Mylan and gave the stock a “buy” rating in a report on Friday, February 16th. Nine research analysts have rated the stock with a hold rating and thirteen have assigned a buy rating to the company. The company presently has an average rating of “Buy” and an average price target of $46.62.
In related news, CEO Heather M. Bresch sold 75,000 shares of the business’s stock in a transaction dated Tuesday, January 9th. The stock was sold at an average price of $45.00, for a total value of $3,375,000.00. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Also, insider Paul Campbell sold 7,030 shares of the business’s stock in a transaction dated Tuesday, March 6th. The stock was sold at an average price of $44.01, for a total value of $309,390.30. Following the transaction, the insider now directly owns 17,054 shares of the company’s stock, valued at approximately $750,546.54. The disclosure for this sale can be found here. In the last ninety days, insiders sold 344,287 shares of company stock valued at $14,409,960. 0.69% of the stock is owned by insiders.
WARNING: This report was reported by The Lincolnian Online and is the property of of The Lincolnian Online. If you are accessing this report on another publication, it was illegally copied and republished in violation of international trademark & copyright laws. The original version of this report can be viewed at https://www.thelincolnianonline.com/2018/03/22/gotham-asset-management-llc-has-13-17-million-position-in-mylan-myl.html.
Mylan N.V. is a global pharmaceutical company. The Company develops, licenses, manufactures, markets and distributes generic and branded generic products for resale by others; specialty pharmaceuticals, and active pharmaceutical ingredients (APIs). It operates through two segments: Generics and Specialty.
Receive News & Ratings for Mylan Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mylan and related companies with MarketBeat.com's FREE daily email newsletter.